Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review: Nutritional regulation of muscle growth in neonatal swine.

Animal : an international journal of animal bioscience·2023
Same author

Treatment prioritization and risk stratification of head and neck cancer during COVID-19 pandemic: A systematic review.

The Medical journal of Malaysia·2022
Same author

The effects of Goldenhar Syndrome on hearing and speech development.

The Medical journal of Malaysia·2021
Same author

Timing resolution studies of the optical part of the AFP Time-of-flight detector.

Optics express·2018
Same author

Mirna biogenesis pathway is differentially regulated during adipose derived stromal/stem cell differentiation.

Adipocyte·2018
Same author

Construction of the optical part of a time-of-flight detector prototype for the AFP detector.

Optics express·2016

Related Experiment Video

Updated: May 11, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Amnion-derived multipotent progenitor cells support allograft tolerance induction.

K Anam1, Y Lazdun, P M Davis

  • 1Department of Regenerative Medicine, Operational and Undersea Medicine Directorate at the Naval Medical Research Center, Silver Spring, MD, USA.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|May 9, 2013
PubMed
Summary

Human amnion-derived multipotent progenitor cells (AMPs) co-infused with bone marrow cells promote long-term graft tolerance and macrochimerism in mice, reducing risks associated with traditional transplantation methods.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

Related Experiment Videos

Last Updated: May 11, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Transplantation Science

Background:

  • High-dose bone marrow cells (BMCs) induce tolerance but risk graft-versus-host disease.
  • Mixed chimerism protocols aim for donor-specific tolerance.

Purpose of the Study:

  • To investigate if co-infusion of human amnion-derived multipotent progenitor cells (AMPs) with BMCs can induce graft tolerance.
  • To evaluate the potential of AMPs as a cellular therapeutic for transplantation.

Main Methods:

  • Mice received skin allografts followed by co-infusion of limited BMCs and AMPs.
  • Minimal conditioning was used prior to cell co-infusion.
  • Chimerism, T cell responses, regulatory T cells (Tregs), and allograft survival were assessed.

Main Results:

  • Co-infusion of AMPs and BMCs induced stable, mixed, multilineage macrochimerism.
  • Donor-reactive T cells were deleted, and regulatory T cells (CD4(+)CD25(+)Foxp3(+)) expanded.
  • Long-term allograft survival (>300 days) was achieved with minimal conditioning.

Conclusions:

  • AMPs, when co-infused with BMCs, facilitate macrochimerism and donor-specific graft tolerance.
  • AMPs show potential as a pro-tolerogenic cellular therapy for solid organ and hematopoietic stem cell transplantation.